No abstract available
Keywords:
Diabetes; GIP; GLP-1; Gastric bypass; Weight loss; glucagon-like peptide-1; glucose-dependent insulinotropic polypeptide.
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Blood Glucose / metabolism
-
Diabetes Mellitus, Type 2 / blood
-
Diabetes Mellitus, Type 2 / drug therapy
-
Diabetes Mellitus, Type 2 / surgery*
-
Female
-
Gastric Bypass / methods*
-
Gastric Inhibitory Polypeptide / metabolism
-
Glipizide / therapeutic use
-
Glucagon-Like Peptide 1 / metabolism
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Insulin Resistance / physiology
-
Metformin / therapeutic use
-
Middle Aged
-
Obesity, Morbid / surgery
-
Postoperative Care
-
Weight Loss
Substances
-
Blood Glucose
-
Hypoglycemic Agents
-
Gastric Inhibitory Polypeptide
-
Glucagon-Like Peptide 1
-
Metformin
-
Glipizide